|
MTERFD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.855090E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.401800E-03 |
| Normal-vs-Stage2 |
4.515500E-03 |
| Normal-vs-Stage3 |
1.644430E-02 |
| Normal-vs-Stage4 |
2.327400E-01 |
| Stage1-vs-Stage2 |
4.814800E-01 |
| Stage1-vs-Stage3 |
9.625800E-01 |
| Stage1-vs-Stage4 |
6.934000E-01 |
| Stage2-vs-Stage3 |
5.724200E-01 |
| Stage2-vs-Stage4 |
3.721600E-01 |
| Stage3-vs-Stage4 |
6.177600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.922800E-03 |
| Normal-vs-AfricanAmerican |
9.756400E-03 |
| Normal-vs-Asian |
5.339000E-01 |
| Caucasian-vs-AfricanAmerican |
7.600200E-01 |
| Caucasian-vs-Asian |
6.201800E-01 |
| AfricanAmerican-vs-Asian |
5.075800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.401830E-03 |
| Normal-vs-Female |
4.125700E-02 |
| Male-vs-Female |
4.441600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.527850E-02 |
| Normal-vs-Extreme_Weight |
1.369760E-02 |
| Normal-vs-Obese |
2.806300E-02 |
| Normal-vs-Extreme_Obese |
4.588000E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.241200E-01 |
| Normal_Weight-vs-Obese |
6.285400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.203200E-01 |
| Extreme_Weight-vs-Obese |
7.013400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.048000E-01 |
| Obese-vs-Extreme_Obese |
5.704200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.098400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.219900E-02 |
| Normal-vs-Age(61-80Yrs) |
6.226900E-04 |
| Normal-vs-Age(81-100Yrs) |
4.598500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.179800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.099200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.467700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.585380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.881800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.811400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.196600E-03 |
| Normal-VS-Type2 PRCC |
1.831650E-02 |
| Normal-VS-KIRP CIMP |
8.668600E-01 |
| Normal-VS-Unclassified PRCC |
9.617400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.477600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.666200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.901200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.214400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.820600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.027800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.15799999999655E-05 |
| Normal-vs-N1 |
4.805000E-01 |
| Normal-vs-N2 |
9.058500E-02 |
| N0-vs-N1 |
1.957910E-02 |
| N0-vs-N2 |
8.204200E-01 |
| N1-vs-N2 |
3.632800E-01 |
|
|
